Senotypes: Mapping Senescent Cell States Across Tissues

July 23, 2026 6 min read
Aging Multi-omics Single-cell

Aging biology is moving past treating “senescent cells” as one homogeneous bucket. Recent multi-omics atlases argue for senotypes — distinct senescent cell states that vary by tissue, program, and molecular context — mapped with single-cell and spatial readouts.

Why this matters

If senescence is a family of states rather than a single phenotype, biomarkers and interventions should be state-aware. That has direct implications for:

  • Aging biomarker panels that generalize across tissues
  • AI signatures trained on heterogeneous single-cell atlases
  • Targeted senotherapeutics that modulate harmful states without blunt cytotoxicity
Computational takeaway: atlas-scale senescence work is as much a data-integration and representation problem as it is a biology problem — batch, tissue, and assay context have to be modeled explicitly if signatures are going to travel.

What I’m watching next

  1. How stable senotype definitions are across cohorts and technologies
  2. Whether spatial context changes which states look “causal” vs bystander
  3. How cleanly these states connect to actionable therapeutic axes

This note expands a short thread I posted on X about multi-omics mapping of senescent cell states.

Expanded from notes I shared on X. For more writing, see the blog index.